PCM
XENT

Pentwater Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Pentwater Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-25,000
Closed -$683K – 243
2021
Q4 		$683K Buy
+25,000
New +$678K 0.01% 183
2020
Q4 		– Sell
-346,500
Closed -$5.65M – 278
2020
Q3 		$5.65M Buy
+346,500
New +$6.28M 0.07% 80

Other funds holding XENT

VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pentwater Capital Management's XENT Position: Q1 2022 in Review

Pentwater Capital Management sold out of Intersect ENT, Inc (XENT) in Q1 2022, closing a stake of 25,000 shares — an estimated $683K sold.

Pentwater Capital Management first reported a position in XENT in Q3 2020 and held it in 2 quarters. The position peaked at $5.65M in Q3 2020. 131 funds tracked by Wall St. Rank hold XENT as of Q1 2022.

  • Pentwater Capital Management reported no remaining Intersect ENT, Inc position as of Q1 2022 after selling out during the quarter.
  • Pentwater Capital Management sold 25,000 Intersect ENT, Inc shares in Q1 2022, an estimated $683K.
  • Pentwater Capital Management first reported a position in Intersect ENT, Inc in Q3 2020 and held it in 2 quarters.
  • Pentwater Capital Management's Intersect ENT, Inc position peaked at $5.65M in Q3 2020.
  • 131 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2022.

Based on Pentwater Capital Management's 13F filing for Q1 2022, filed 16 May 2022.